Akut mieloid leukémia (AML): vizsgálatok itt: Kína
226 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- Korai 1. fázisTaking peopleXP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06980155 - 2. fázisTaking peopleThiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
- Where
- Beijing
- Életkor
- 55 év to 70 év
- People
- 56
- Run by
- Peking University People's Hospital
See details and how to joinNCT06869265 - 2/3. fázisTaking peopleMolecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Shanghai
- Életkor
- 14 év to 75 év
- People
- 126
- Run by
- Ruijin Hospital
See details and how to joinNCT06972641 - No phaseCsak meghívásosDaunorubicin + Cytarabine + Venetoclax in de Novo AML
- Where
- Hefei
- Életkor
- 18 év to 59 év
- People
- 94
- Run by
- Anhui Medical University
See details and how to joinNCT06697327 - 1/2. fázisTaking peoplePhase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Guangzhou, Hangzhou
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Guangzhou Bio-gene Technology Co., Ltd
See details and how to joinNCT06118788 - 1/2. fázisTaking peopleThe Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 90
- Run by
- Tianjin Medical University General Hospital
See details and how to joinNCT06911710 - 2. fázisNot yet taking people in KínaSelinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
- Where
- Tianjin
- Életkor
- 16 év to 75 év
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088 - 1. fázisTaking peopleUCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
- Where
- Wuhan
- Életkor
- 18 év to 60 év
- People
- 9
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06245746 - 1. fázisTaking peopleA Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 84
- Run by
- Zhejiang ACEA Pharmaceutical Co. Ltd.
See details and how to joinNCT05947344 - No phaseTaking peopleA Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
- Where
- Suzhou
- Életkor
- 14 év to 70 év
- People
- 40
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06879847 - Korai 1. fázisTaking peopleOff-the-shelf CD123 CAR-NK for R/R AML
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 12
- Run by
- Peking University People's Hospital
See details and how to joinNCT06201247 - 1. fázisTaking peopleCD123-CD16-NK Cells Immunotherapy for AML
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 9
- Run by
- Chunji Gao
See details and how to joinNCT06835140 - 1. fázisTaking peopleDose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
- Where
- Xiamen
- Életkor
- 60 év to 75 év
- People
- 18
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06651866 - 1. fázisTaking peopleChiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
- Where
- Xiamen
- Életkor
- 18 év and over
- People
- 30
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06737523 - No phaseNot yet taking people in KínaStudy of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 18 év to 60 év
- People
- 158
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06841952 - 2. fázisTaking peopleVeneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
- Where
- Xiamen
- Életkor
- 60 év and over
- People
- 66
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06827899 - 2. fázisTaking peopleVCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Xiamen
- Életkor
- 60 év and over
- People
- 66
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT05603884 - 2. fázisTaking peopleChemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia
- Where
- Shanghai
- Életkor
- 16 év to 65 év
- People
- 100
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05870995 - 3. fázisTaking peopleRandomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
- Where
- Fuzhou, Kunming, Nanjin, Nanning, Shanghai, Suzhou, Xiamen
- Életkor
- 16 év to 55 év
- People
- 222
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05991908 - 3. fázisTaking peopleConditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 120
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06829472 - 3. fázisTaking peopleHVA vs IA/DA or VA in the Treatment of ND HR-AML
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 876
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06810791 - 3. fázisTaking peopleInterferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 96
- Run by
- Peking University People's Hospital
See details and how to joinNCT06802718 - Korai 1. fázisNot yet taking people in KínaClinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06786299 - 2. fázisTaking peopleAvapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06783790 - 2. fázisNot yet taking people in KínaAvapritinib Maintenance for AML With KIT Mutations
- Where
- Shanghai
- Életkor
- 14 év to 70 év
- People
- 47
- Run by
- Ruijin Hospital
See details and how to joinNCT06765915